Results 171 to 180 of about 332,661 (303)

Myeloid Cell-Targeting PLGA Nanoparticles Ameliorate Acute Graft-Versus-Host Disease. [PDF]

Cancers (Basel)
Galvin JP, Beddow SA, Lust HP, Xu D, Arellano G, Neef T, Lin AY, Miller SD.   +7 more
europepmc   +1 more source

Craniofacial Resection for Advanced Cutaneous Squamous Cell Carcinoma: Results From the 2nd International Collaborative Case‐Series

Head &Neck, EarlyView.
ABSTRACT Background Robust outcome data for anterior skull base cutaneous squamous cell carcinoma (cSCC) are limited, particularly as emerging therapies reshape management. We evaluated survival and prognostic factors following craniofacial resection. Methods Retrospective multi‐institutional case‐series (1995–2015) of patients who underwent skull base
Michael J. C. Schachtel, Benedict J. Panizza, James J. Bowman, Catherine Barnett, Cristina Valero, Ian Ganly, Snehal G. Patel, Helena Levyn, Dauren Adilbay, Alana Eagan, Marc A. Cohen, Lillian A. Boe, Junting Zheng, Mithat Gonen, Prathamesh Pai, Paolo Castelnuovo, Fang Ju Gao, Cesare Piazza, Piero Nicolai, Luiz P. Kowalski, Ronaldo N. Toledo, Claudio Cernea, Sergio Goncalves, Dan M. Fliss, John R. de Almeida, Ian Witterick, Philippe Herman, Walter Fontanella, Gregorio Sanchez Aniceto, Alvaro Rivero Calle, Sefik Hosal, Serdar Ozer, Subramania Iyer, Richard J. Harvey, C. Rene Leemans, Jan‐Jaap Hendrickx, Marcelo Figari, Luis Boccalatte, Ken Ichi Nibu, Peter Clarke, Catherine Rennie, Yiming Zhu, Rodney J. Schlosser, Fernando L. Dias, Zoukaa Sargi, Shahzada Ahmed, Wojciech Golusinski, Se Heon Kim, Shirley Y. Su, Shaan M. Raza, Franco DeMonte, Ehab Hanna, Jatin P. Shah   +52 more
wiley   +1 more source

BCL2 overexpression in donor lymphocytes reduces the risk of graft-versus-host disease. [PDF]

Blood Adv
Bejarano-García JA, Nufer M, Palacios-Barea MJ, Guijarro-Albaladejo B, Sierro-Martínez B, Bella Á, Robles-Benítez C, García-Guerrero E, Carrasco-Brocal I, Lara-Chica M, Sanoja-Flores L, Mendendez NV, Caballero-Velázquez T, Rodríguez-Gil A, Pérez-Simón JA.   +14 more
europepmc   +1 more source

Assessment of Vedolizumab and UC-MSC interaction and therapeutic potential in acute graft-versus-host-disease. [PDF]

Front Cell Dev Biol
Merlo A, Zilio S, Bernardi M, Catanzaro D, Galla L, Zocca L, Marini O, Piccoli M, Tosetto A, Qi W, Marigo I, Elice F, Astori G.   +12 more
europepmc   +1 more source

Antibiotic risk score for acute graft-versus-host disease. [PDF]

Blood Adv
Rashidi A, Gao F.
europepmc   +1 more source

Reproducibility and repeatability of the Myoton to quantify sclerotic chronic graft-versus-host disease. [PDF]

Blood Adv
Farhadfar N, El Jurdi N, Baker KK, Ghosh S, Bat-Erdene M, Chen H, Sahu R, Weiss R, Mi J, Desatnik G, Williams LR, Tkaczyk ER, Lee SJ.   +12 more
europepmc   +1 more source

Chronic graft-versus-host disease in long-term survivors of childhood leukemia. [PDF]

Hemasphere
Saultier P, Michel G, Sirvent A, Renard C, Tabone MD, Leverger G, Baruchel A, Pochon C, Paillard C, Jubert C, Ducassou S, Poirée M, Strullu M, Fahd M, Visentin S, Stérin A, Plantaz D, Kanold J, Gandemer V, Theron A, Raus N, Thouvenin-Doulet S, Domenech C, Berbis J, Auquier P, Dalle JH.   +25 more
europepmc   +1 more source

Extracorporeal photopheresis alone or in combination with ruxolitinib for the treatment of chronic graft-versus-host disease. [PDF]

Front Immunol
Koch C, Manz MG, Nägeli M, Schneidawind D.   +3 more
europepmc   +1 more source

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Steroid-Refractory Chronic Graft-Versus-Host Disease-Associated Isolated Myositis Successfully Treated With Ruxolitinib: A Case Report. [PDF]

EJHaem
Kumamoto T, Yoshihara K, Matsuda I, Urase A, Ikunari R, Takahashi S, Samori M, Hirota S, Ohe C, Yoshihara S.   +9 more
europepmc   +1 more source